nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—HTR2B—cardial valve—dilated cardiomyopathy	0.167	0.446	CbGeAlD
Amisulpride—HTR7—pulmonary artery—dilated cardiomyopathy	0.0578	0.155	CbGeAlD
Amisulpride—HTR7—sympathetic nervous system—dilated cardiomyopathy	0.0562	0.15	CbGeAlD
Amisulpride—Central nervous system disorder—Furosemide—dilated cardiomyopathy	0.0451	0.105	CcSEcCtD
Amisulpride—HTR2A—pulmonary artery—dilated cardiomyopathy	0.0361	0.0964	CbGeAlD
Amisulpride—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.0351	0.0938	CbGeAlD
Amisulpride—Breast pain—Spironolactone—dilated cardiomyopathy	0.0191	0.0442	CcSEcCtD
Amisulpride—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.0189	0.0439	CcSEcCtD
Amisulpride—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.0149	0.0345	CcSEcCtD
Amisulpride—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00961	0.0223	CcSEcCtD
Amisulpride—HTR2B—heart—dilated cardiomyopathy	0.00922	0.0246	CbGeAlD
Amisulpride—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00886	0.0206	CcSEcCtD
Amisulpride—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00868	0.0201	CcSEcCtD
Amisulpride—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.00819	0.019	CcSEcCtD
Amisulpride—HTR7—heart—dilated cardiomyopathy	0.00789	0.0211	CbGeAlD
Amisulpride—Breast pain—Lisinopril—dilated cardiomyopathy	0.00778	0.0181	CcSEcCtD
Amisulpride—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00699	0.0162	CcSEcCtD
Amisulpride—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00679	0.0158	CcSEcCtD
Amisulpride—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00679	0.0158	CcSEcCtD
Amisulpride—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00659	0.0153	CcSEcCtD
Amisulpride—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00651	0.0151	CcSEcCtD
Amisulpride—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.006	0.0139	CcSEcCtD
Amisulpride—Somnolence—Spironolactone—dilated cardiomyopathy	0.00527	0.0122	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00512	0.0119	CcSEcCtD
Amisulpride—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00512	0.0119	CcSEcCtD
Amisulpride—HTR2A—heart—dilated cardiomyopathy	0.00492	0.0132	CbGeAlD
Amisulpride—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00472	0.011	CcSEcCtD
Amisulpride—Urticaria—Spironolactone—dilated cardiomyopathy	0.00471	0.0109	CcSEcCtD
Amisulpride—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00469	0.0109	CcSEcCtD
Amisulpride—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.0045	0.0104	CcSEcCtD
Amisulpride—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00437	0.0101	CcSEcCtD
Amisulpride—Pruritus—Spironolactone—dilated cardiomyopathy	0.0042	0.00974	CcSEcCtD
Amisulpride—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00415	0.00963	CcSEcCtD
Amisulpride—Angiopathy—Furosemide—dilated cardiomyopathy	0.00412	0.00957	CcSEcCtD
Amisulpride—Immune system disorder—Furosemide—dilated cardiomyopathy	0.0041	0.00952	CcSEcCtD
Amisulpride—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00406	0.00942	CcSEcCtD
Amisulpride—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00398	0.00924	CcSEcCtD
Amisulpride—Malnutrition—Furosemide—dilated cardiomyopathy	0.00395	0.00918	CcSEcCtD
Amisulpride—Dizziness—Spironolactone—dilated cardiomyopathy	0.00392	0.0091	CcSEcCtD
Amisulpride—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00392	0.0091	CcSEcCtD
Amisulpride—Weight increased—Lisinopril—dilated cardiomyopathy	0.00388	0.00899	CcSEcCtD
Amisulpride—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00385	0.00894	CcSEcCtD
Amisulpride—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00384	0.00891	CcSEcCtD
Amisulpride—Muscle spasms—Furosemide—dilated cardiomyopathy	0.0038	0.00882	CcSEcCtD
Amisulpride—Depression—Lisinopril—dilated cardiomyopathy	0.00379	0.00879	CcSEcCtD
Amisulpride—Vomiting—Spironolactone—dilated cardiomyopathy	0.00377	0.00875	CcSEcCtD
Amisulpride—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00372	0.00864	CcSEcCtD
Amisulpride—Headache—Spironolactone—dilated cardiomyopathy	0.00372	0.00862	CcSEcCtD
Amisulpride—Agitation—Furosemide—dilated cardiomyopathy	0.00363	0.00843	CcSEcCtD
Amisulpride—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00354	0.00822	CcSEcCtD
Amisulpride—Leukopenia—Furosemide—dilated cardiomyopathy	0.00354	0.00822	CcSEcCtD
Amisulpride—Nausea—Spironolactone—dilated cardiomyopathy	0.00352	0.00818	CcSEcCtD
Amisulpride—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00347	0.00805	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00334	0.00776	CcSEcCtD
Amisulpride—Dry mouth—Furosemide—dilated cardiomyopathy	0.00329	0.00764	CcSEcCtD
Amisulpride—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00317	0.00735	CcSEcCtD
Amisulpride—Skin disorder—Furosemide—dilated cardiomyopathy	0.00314	0.00728	CcSEcCtD
Amisulpride—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00312	0.00724	CcSEcCtD
Amisulpride—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00309	0.00718	CcSEcCtD
Amisulpride—Hypotension—Furosemide—dilated cardiomyopathy	0.00302	0.007	CcSEcCtD
Amisulpride—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00299	0.00693	CcSEcCtD
Amisulpride—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00297	0.00689	CcSEcCtD
Amisulpride—Tension—Lisinopril—dilated cardiomyopathy	0.00291	0.00676	CcSEcCtD
Amisulpride—Nervousness—Lisinopril—dilated cardiomyopathy	0.00288	0.00669	CcSEcCtD
Amisulpride—Somnolence—Furosemide—dilated cardiomyopathy	0.00287	0.00666	CcSEcCtD
Amisulpride—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00285	0.00662	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00279	0.00647	CcSEcCtD
Amisulpride—Fatigue—Furosemide—dilated cardiomyopathy	0.00278	0.00646	CcSEcCtD
Amisulpride—Tremor—Lisinopril—dilated cardiomyopathy	0.00278	0.00645	CcSEcCtD
Amisulpride—Constipation—Furosemide—dilated cardiomyopathy	0.00276	0.00641	CcSEcCtD
Amisulpride—Angioedema—Lisinopril—dilated cardiomyopathy	0.00271	0.00629	CcSEcCtD
Amisulpride—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00266	0.00616	CcSEcCtD
Amisulpride—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00264	0.00612	CcSEcCtD
Amisulpride—Urticaria—Furosemide—dilated cardiomyopathy	0.00256	0.00595	CcSEcCtD
Amisulpride—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00255	0.00592	CcSEcCtD
Amisulpride—Anxiety—Lisinopril—dilated cardiomyopathy	0.00252	0.00584	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00251	0.00582	CcSEcCtD
Amisulpride—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00247	0.00573	CcSEcCtD
Amisulpride—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00238	0.00552	CcSEcCtD
Amisulpride—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00235	0.00546	CcSEcCtD
Amisulpride—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00234	0.00543	CcSEcCtD
Amisulpride—Asthenia—Furosemide—dilated cardiomyopathy	0.00232	0.00537	CcSEcCtD
Amisulpride—Pruritus—Furosemide—dilated cardiomyopathy	0.00228	0.0053	CcSEcCtD
Amisulpride—Hypotension—Lisinopril—dilated cardiomyopathy	0.00226	0.00525	CcSEcCtD
Amisulpride—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00221	0.00512	CcSEcCtD
Amisulpride—Insomnia—Lisinopril—dilated cardiomyopathy	0.00219	0.00508	CcSEcCtD
Amisulpride—Somnolence—Lisinopril—dilated cardiomyopathy	0.00215	0.005	CcSEcCtD
Amisulpride—Dizziness—Furosemide—dilated cardiomyopathy	0.00213	0.00495	CcSEcCtD
Amisulpride—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00213	0.00495	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00209	0.00485	CcSEcCtD
Amisulpride—Fatigue—Lisinopril—dilated cardiomyopathy	0.00209	0.00485	CcSEcCtD
Amisulpride—Constipation—Lisinopril—dilated cardiomyopathy	0.00207	0.00481	CcSEcCtD
Amisulpride—Vomiting—Furosemide—dilated cardiomyopathy	0.00205	0.00476	CcSEcCtD
Amisulpride—Headache—Furosemide—dilated cardiomyopathy	0.00202	0.00469	CcSEcCtD
Amisulpride—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00198	0.0046	CcSEcCtD
Amisulpride—Urticaria—Lisinopril—dilated cardiomyopathy	0.00192	0.00446	CcSEcCtD
Amisulpride—Nausea—Furosemide—dilated cardiomyopathy	0.00192	0.00445	CcSEcCtD
Amisulpride—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00191	0.00444	CcSEcCtD
Amisulpride—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00178	0.00414	CcSEcCtD
Amisulpride—Asthenia—Lisinopril—dilated cardiomyopathy	0.00174	0.00403	CcSEcCtD
Amisulpride—Pruritus—Lisinopril—dilated cardiomyopathy	0.00171	0.00398	CcSEcCtD
Amisulpride—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00166	0.00385	CcSEcCtD
Amisulpride—Dizziness—Lisinopril—dilated cardiomyopathy	0.0016	0.00372	CcSEcCtD
Amisulpride—Vomiting—Lisinopril—dilated cardiomyopathy	0.00154	0.00357	CcSEcCtD
Amisulpride—Headache—Lisinopril—dilated cardiomyopathy	0.00152	0.00352	CcSEcCtD
Amisulpride—Nausea—Lisinopril—dilated cardiomyopathy	0.00144	0.00334	CcSEcCtD
Amisulpride—HTR7—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000713	0.00365	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000712	0.00365	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000712	0.00365	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000711	0.00365	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000695	0.00356	CbGpPWpGaD
Amisulpride—HTR7—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000689	0.00353	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000689	0.00353	CbGpPWpGaD
Amisulpride—HTR2B—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000687	0.00352	CbGpPWpGaD
Amisulpride—DRD2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000685	0.00351	CbGpPWpGaD
Amisulpride—DRD2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000685	0.00351	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000662	0.00339	CbGpPWpGaD
Amisulpride—HTR2B—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000651	0.00334	CbGpPWpGaD
Amisulpride—HTR7—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000644	0.0033	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000641	0.00329	CbGpPWpGaD
Amisulpride—DRD3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000639	0.00328	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000637	0.00327	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000637	0.00327	CbGpPWpGaD
Amisulpride—DRD2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000637	0.00327	CbGpPWpGaD
Amisulpride—DRD2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000636	0.00326	CbGpPWpGaD
Amisulpride—HTR2A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000625	0.00321	CbGpPWpGaD
Amisulpride—HTR2B—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000625	0.0032	CbGpPWpGaD
Amisulpride—HTR2A—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.000622	0.00319	CbGpPWpGaD
Amisulpride—HTR7—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000611	0.00313	CbGpPWpGaD
Amisulpride—DRD3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000606	0.00311	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000603	0.00309	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000593	0.00304	CbGpPWpGaD
Amisulpride—DRD2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000591	0.00303	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000588	0.00302	CbGpPWpGaD
Amisulpride—DRD3—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000586	0.003	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000582	0.00299	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000582	0.00299	CbGpPWpGaD
Amisulpride—HTR2A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000581	0.00298	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000574	0.00294	CbGpPWpGaD
Amisulpride—DRD2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000572	0.00293	CbGpPWpGaD
Amisulpride—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000563	0.00289	CbGpPWpGaD
Amisulpride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000559	0.00287	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000558	0.00286	CbGpPWpGaD
Amisulpride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000556	0.00285	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000547	0.00281	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000545	0.00279	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000545	0.00279	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000542	0.00278	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000542	0.00278	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000542	0.00278	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000536	0.00275	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000536	0.00275	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000524	0.00269	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000519	0.00266	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000506	0.0026	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000504	0.00258	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000498	0.00255	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00049	0.00251	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00049	0.00251	CbGpPWpGaD
Amisulpride—DRD2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000489	0.00251	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000488	0.0025	CbGpPWpGaD
Amisulpride—DRD3—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000484	0.00248	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000482	0.00247	CbGpPWpGaD
Amisulpride—HTR2A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000481	0.00247	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000465	0.00238	CbGpPWpGaD
Amisulpride—DRD2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000464	0.00238	CbGpPWpGaD
Amisulpride—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000456	0.00234	CbGpPWpGaD
Amisulpride—HTR7—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000453	0.00232	CbGpPWpGaD
Amisulpride—DRD2—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000448	0.0023	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000448	0.0023	CbGpPWpGaD
Amisulpride—HTR2A—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000438	0.00224	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000425	0.00218	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000419	0.00215	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000417	0.00214	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000415	0.00213	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000415	0.00213	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000414	0.00212	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000412	0.00211	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000408	0.00209	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000408	0.00209	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000397	0.00204	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000395	0.00203	CbGpPWpGaD
Amisulpride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000392	0.00201	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000391	0.002	CbGpPWpGaD
Amisulpride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000388	0.00199	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000386	0.00198	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000385	0.00197	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000379	0.00195	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000373	0.00191	CbGpPWpGaD
Amisulpride—DRD2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000371	0.0019	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000367	0.00188	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00036	0.00185	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00036	0.00185	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000345	0.00177	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000335	0.00172	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000329	0.00169	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000329	0.00169	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000327	0.00168	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000327	0.00168	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000324	0.00166	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000319	0.00164	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000315	0.00162	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000314	0.00161	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000306	0.00157	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000306	0.00157	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000306	0.00157	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000304	0.00156	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000303	0.00155	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000299	0.00153	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000299	0.00153	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000298	0.00153	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000296	0.00152	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000295	0.00151	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000295	0.00151	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000293	0.0015	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00029	0.00149	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000285	0.00146	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000278	0.00143	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000278	0.00143	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000278	0.00142	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000277	0.00142	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000276	0.00141	CbGpPWpGaD
Amisulpride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000272	0.00139	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000269	0.00138	CbGpPWpGaD
Amisulpride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000266	0.00136	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000263	0.00135	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000259	0.00133	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000253	0.0013	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000252	0.00129	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00025	0.00128	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00024	0.00123	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000239	0.00122	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000236	0.00121	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000234	0.0012	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000234	0.0012	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000231	0.00118	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000231	0.00118	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00023	0.00118	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000229	0.00118	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000224	0.00115	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000223	0.00115	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000221	0.00113	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000218	0.00112	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000218	0.00112	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000218	0.00112	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000214	0.0011	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000214	0.0011	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000213	0.00109	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000213	0.00109	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000211	0.00108	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000209	0.00107	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000209	0.00107	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000208	0.00106	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000204	0.00105	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000203	0.00104	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000199	0.00102	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000198	0.00101	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000195	0.000999	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000195	0.000998	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000193	0.000991	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000193	0.000991	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000192	0.000983	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000189	0.000967	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000186	0.000956	CbGpPWpGaD
Amisulpride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000186	0.000956	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000185	0.00095	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000185	0.000949	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00018	0.000924	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00018	0.000921	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000178	0.000913	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000177	0.000909	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000177	0.000908	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000177	0.000905	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000177	0.000905	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000174	0.000892	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000173	0.000889	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000171	0.000877	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000169	0.000868	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000168	0.000863	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000166	0.00085	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000164	0.000842	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000164	0.000842	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000164	0.000842	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000164	0.000839	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000162	0.000829	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000161	0.000826	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000159	0.000815	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000158	0.000808	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000155	0.000796	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000153	0.000783	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000153	0.000783	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000151	0.000772	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000149	0.000762	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000148	0.000759	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000142	0.000726	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000141	0.000723	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000139	0.000714	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000136	0.000696	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000133	0.000681	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000131	0.00067	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000129	0.000661	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000127	0.00065	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000126	0.000648	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000126	0.000645	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000126	0.000645	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000125	0.00064	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000124	0.000634	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000124	0.000634	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000123	0.00063	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000121	0.000621	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000121	0.000618	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00012	0.000615	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000119	0.000608	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000117	0.000599	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000115	0.000591	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000115	0.00059	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000113	0.000581	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000113	0.00058	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000112	0.000576	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000111	0.000571	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000111	0.000568	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000109	0.000561	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AGT—dilated cardiomyopathy	0.000105	0.000536	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000104	0.000536	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000103	0.000528	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.0001	0.000513	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.67e-05	0.000496	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AGT—dilated cardiomyopathy	9.55e-05	0.00049	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.51e-05	0.000488	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—RAC1—dilated cardiomyopathy	9.31e-05	0.000477	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.17e-05	0.00047	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.02e-05	0.000463	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AGT—dilated cardiomyopathy	8.89e-05	0.000456	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.42e-05	0.000432	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.99e-05	0.00041	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.88e-05	0.000404	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.86e-05	0.000403	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.75e-05	0.000398	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.7e-05	0.000395	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—RAF1—dilated cardiomyopathy	7.26e-05	0.000372	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.16e-05	0.000367	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	7.12e-05	0.000365	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	7.01e-05	0.000359	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	6.8e-05	0.000349	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	6.69e-05	0.000343	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—RAF1—dilated cardiomyopathy	6.63e-05	0.00034	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—RAF1—dilated cardiomyopathy	6.17e-05	0.000316	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.48e-05	0.000281	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.39e-05	0.000277	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—EGFR—dilated cardiomyopathy	4.98e-05	0.000255	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	4.72e-05	0.000242	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.65e-05	0.000238	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—EGFR—dilated cardiomyopathy	4.55e-05	0.000233	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—EGFR—dilated cardiomyopathy	4.23e-05	0.000217	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	3.24e-05	0.000166	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.19e-05	0.000163	CbGpPWpGaD
